Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles

BACKGROUND: Design and analysis of clinical trials for rare and ultra-rare disease pose unique challenges to the practitioners. Meeting conventional power requirements is infeasible for diseases where sample sizes are inherently very small. Moreover, rare disease populations are generally heterogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Kidwell, Kelley M., Roychoudhury, Satrajit, Wendelberger, Barbara, Scott, John, Moroz, Tara, Yin, Shaoming, Majumder, Madhurima, Zhong, John, Huml, Raymond A., Miller, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077995/
https://www.ncbi.nlm.nih.gov/pubmed/35526036
http://dx.doi.org/10.1186/s13023-022-02342-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077995/
https://www.ncbi.nlm.nih.gov/pubmed/35526036
http://dx.doi.org/10.1186/s13023-022-02342-5

Ejemplares similares